Abstract
To characterize the patterns of brain atrophy and perfusion as measured by arterial spin labeling (ASL)-MRI, in amyotrophic lateral sclerosis (ALS) patients with varying levels of cognitive deficit, including ALS with frontotemporal dementia (FTD). A total of 55 ALS patients and 20 healthy controls (HCs) were included, and all participants underwent neuropsychological assessments and MRI scans. According to their cognitive performance, ALS patients were further subclassified into ALS with normal cognition (ALS-Cn, n = 27), ALS with cognitive impairment (ALS-Ci, n = 17), and ALS-FTD (n = 11). Voxel-based comparisons of gray matter (GM) changes and cerebral blood flow (CBF) were conducted among the subgroups. The whole-brain comparisons of GM changes and CBF among ALS-Ci, ALS-Cn, and HCs were not significantly different. However, the ALS-FTD patients demonstrated a similar pattern of GM loss and hypoperfusion with more significant alterations in the left frontal and temporal lobe compared with the HCs, ALS-Cn, and ALS-Ci patients. Decreased CBF was found in many of the same brain areas wherein structural alterations occurred, although isolated GM loss and hypoperfusion were also observed. In addition, for both GM and CBF abnormalities, a similar pattern of changes was found in the comparisons of ALS-FTD vs. ALS-Ci, ALS-FTD vs. ALS-Cn, and ALS-FTD vs. HCs, with the differences being most significant between ALS-FTD and HCs. The cognitive status of ALS patients is associated with different patterns of GM changes and cerebral perfusion. ASL-MRI might be a useful tool with which to investigate the pathological burden of ALS and to disclose the early signature of possible cognitive impairment.
Highlights
Amyotrophic lateral sclerosis (ALS) is a progressive neurode generative disease involving both upper and lower motor neurons with no effective cure
Patients with ALS could display a spectrum of cogni tive and behavioral deficits ranging from mild deficits to severe frontotemporal dementia (FTD) [2]
It is noteworthy that a similar atrophy pattern was found in the comparisons of ALS-FTD vs. ALS patients with cognitive impairment (ALS-Ci), ALS-FTD vs. ALS with normal cognition (ALS-Cn), and ALS-FTD vs. healthy controls (HCs), with the size of the areas of involvement and the significance of the differences increasing in the above order
Summary
Amyotrophic lateral sclerosis (ALS) is a progressive neurode generative disease involving both upper and lower motor neurons with no effective cure. An estimated 35–40% of individuals with ALS may display fully developed FTD, and 30–60% exhibit more subtle cognitive alterations involving executive domains, social cognition, language, or memory, or present with neuropsychi atric symptoms [4,5,6,7,8]. These deficits are manifestations of the spectrum of disorders resulting from frontotemporal dysfunction in patients with ALS [3]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.